BioSpace News Archive

Median Technologies, a World Leading Oncology Clinical Trial Imaging Services Provider, Becomes Preferred Vendor to Another Top 3 Pharmaceutical Company

Regulatory News: Median Technologies announced that the Company has been selected as preferred vendor by a Top 3 pharmaceutical company, adding another one of the largest global pharmaceutical companies to its client portfolio.

May 21, 2024
·
3 min read
BioCapital

Inspire and Takeda Researchers to Present Novel Study on Short Bowel Syndrome Patient Experience at DDW2024

Inspire, the world’s largest health community and real-world evidence platform, has announced that it will present new research at Digestive Disease Week 2024, unveiling insights from a mixed-method study on Short Bowel Syndrome patient experience.

May 21, 2024
·
3 min read
Business

Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings

Incyte announced the expansion of its presence in Delaware with the acquisition of two buildings at 1100 North King Street and 1100 North French Street in downtown Wilmington.

May 21, 2024
·
5 min read
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American Thoracic Society (ATS) 2024 International Conference that is being held from May 17-22, 2024 in San Diego.

May 21, 2024
·
11 min read
Business

Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update

Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”) today reported financial information for the first quarter of 2024, including its cash, cash equivalents and revenues, and provided a corporate update.

May 21, 2024
·
15 min read
Genetown

Relay Therapeutics to Participate in Upcoming Investor Conferences - May 21, 2024

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, announced that management will participate in two upcoming fireside chats.

May 21, 2024
·
1 min read
Trinity Biotech plc to Announce Q1 2024 Financial Results

Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, will report financial results for the first quarter 2024 on Thursday, May 23, 2024 at 8:30 AM ET.

May 21, 2024
·
1 min read
Genetown

LeMaitre to Present at the 2024 Jefferies Global Healthcare Conference

LeMaitre Vascular, Inc. announced that George W. LeMaitre, Chairman & CEO, will present at the 2024 Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 11:00 AM ET at the Marriott Marquis in New York City.

May 21, 2024
·
1 min read
Drug Development

Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX) today announced additional positive clinical data from its Phase 1b/2a RESOLVE trial, which is evaluating the safety and efficacy of EP-104GI as a treatment for eosinophilic esophagitis (“EoE”).

May 21, 2024
·
9 min read
Business

Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update

Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first three months of 2024 and provided a summary of recent corporate highlights.

May 21, 2024
·
21 min read